INTU vs PACB · P/E 64, rev $18.83B vs rev $76.2M
Intuit Inc (INTU) versus Pacific Biosciences of California (PACB) — a side-by-side from cached financials, not a winner call.
Intuit Inc (INTU) is a software - application company listed on US.
Pacific Biosciences of California (PACB) is a medical devices company listed on US.
Latest reported INTU revenue for 2025-07-31 was $18.83B. Net income was $3.87B. INTU currently screens at market cap $217.76B and trailing P/E 63.7.
Latest reported PACB revenue for 2026-06-30 was $76.2M. Net income was -$53.0M. PACB currently screens at market cap $387.1M.
INTU currently screens at market cap $217.76B and trailing P/E 63.7. PACB currently screens at market cap $387.1M.
Not investment advice. Open the INTU and PACB stock pages for the full models.
Not investment advice.